372 related articles for article (PubMed ID: 22875755)
1. Interpreting incremental value of markers added to risk prediction models.
Pencina MJ; D'Agostino RB; Pencina KM; Janssens AC; Greenland P
Am J Epidemiol; 2012 Sep; 176(6):473-81. PubMed ID: 22875755
[TBL] [Abstract][Full Text] [Related]
2. Clinically relevant measures of fit? A note of caution.
Cook NR
Am J Epidemiol; 2012 Sep; 176(6):488-91. PubMed ID: 22875759
[TBL] [Abstract][Full Text] [Related]
3. Understanding increments in model performance metrics.
Pencina MJ; D'Agostino RB; Massaro JM
Lifetime Data Anal; 2013 Apr; 19(2):202-18. PubMed ID: 23242535
[TBL] [Abstract][Full Text] [Related]
4. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.
Pencina MJ; D'Agostino RB; Demler OV
Stat Med; 2012 Jan; 31(2):101-13. PubMed ID: 22147389
[TBL] [Abstract][Full Text] [Related]
5. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
[TBL] [Abstract][Full Text] [Related]
6. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
[TBL] [Abstract][Full Text] [Related]
7. Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve.
Mihaescu R; van Zitteren M; van Hoek M; Sijbrands EJ; Uitterlinden AG; Witteman JC; Hofman A; Hunink MG; van Duijn CM; Janssens AC
Am J Epidemiol; 2010 Aug; 172(3):353-61. PubMed ID: 20562194
[TBL] [Abstract][Full Text] [Related]
8. Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context.
Kerr KF; Bansal A; Pepe MS
Am J Epidemiol; 2012 Sep; 176(6):482-7. PubMed ID: 22875756
[TBL] [Abstract][Full Text] [Related]
9. The power-integrated discriminant improvement: An accurate measure of the incremental predictive value of additional biomarkers.
Hayashi K; Eguchi S
Stat Med; 2019 Jun; 38(14):2589-2604. PubMed ID: 30859601
[TBL] [Abstract][Full Text] [Related]
10. Statistical methods for assessment of added usefulness of new biomarkers.
Pencina MJ; D'Agostino RB; Vasan RS
Clin Chem Lab Med; 2010 Dec; 48(12):1703-11. PubMed ID: 20716010
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
Pencina MJ; D'Agostino RB; D'Agostino RB; Vasan RS
Stat Med; 2008 Jan; 27(2):157-72; discussion 207-12. PubMed ID: 17569110
[TBL] [Abstract][Full Text] [Related]
12. Small improvement in the area under the receiver operating characteristic curve indicated small changes in predicted risks.
Martens FK; Tonk EC; Kers JG; Janssens AC
J Clin Epidemiol; 2016 Nov; 79():159-164. PubMed ID: 27430730
[TBL] [Abstract][Full Text] [Related]
13. Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.
Enserro DM; Demler OV; Pencina MJ; D'Agostino RB
Stat Med; 2019 Sep; 38(20):3817-3831. PubMed ID: 31211443
[TBL] [Abstract][Full Text] [Related]
14. [Discriminative ability, reclassification and net benefit: the predictive value of biomarkers].
Steyerberg EW; Pencina MJ; Van Calster B
Ned Tijdschr Geneeskd; 2012; 156(41):A5029. PubMed ID: 23062255
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the value of biomarkers for predicting mortality.
Goldman N; Glei DA
Ann Epidemiol; 2015 Dec; 25(12):901-6.e1-4. PubMed ID: 26419291
[TBL] [Abstract][Full Text] [Related]
16. Net reclassification index at event rate: properties and relationships.
Pencina MJ; Steyerberg EW; D'Agostino RB
Stat Med; 2017 Dec; 36(28):4455-4467. PubMed ID: 27426413
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of polygenic risk models using multiple performance measures: a critical assessment of discordant results.
Martens FK; Tonk ECM; Janssens ACJW
Genet Med; 2019 Feb; 21(2):391-397. PubMed ID: 29895851
[TBL] [Abstract][Full Text] [Related]
18. What to expect from net reclassification improvement with three categories.
Pencina KM; Pencina MJ; D'Agostino RB
Stat Med; 2014 Dec; 33(28):4975-87. PubMed ID: 25176621
[TBL] [Abstract][Full Text] [Related]
19. Misuse of DeLong test to compare AUCs for nested models.
Demler OV; Pencina MJ; D'Agostino RB
Stat Med; 2012 Oct; 31(23):2577-87. PubMed ID: 22415937
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
